PB2003: REAL-WORLD TREATMENT PATTERNS OF PATIENTS (PTS) WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (MDS) IN A US REAL-WORLD EVIDENCE DATABASE (COTA)

• Rami S. Komrokji,
• Leyla Hernandez- Donoso,
• Sejla Hodzic,
• Henry Owusu,
• Kevin Nolan,
• Claire Nourry,
• María Díez Campelo

Affiliations

Rami S. Komrokji

1 Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, United States

Leyla Hernandez- Donoso

2 Novartis Pharma AG, Basel, Switzerland

Sejla Hodzic

3 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States

Henry Owusu

2 Novartis Pharma AG, Basel, Switzerland

Kevin Nolan

4 Novartis Pharma AG, Basel, Switzerland

Claire Nourry

4 Novartis Pharma AG, Basel, Switzerland

María Díez Campelo

5 Hematology Department, The University Hospital of Salamanca Salamanca,, Salamanca, Spain